Medregen has initiated its proof of concept, phase II study ‘Safety and Efficacy of MRG-001 in Wound Healing and Scar Appearance...
Medregen is proud to announce that the results of the phase I study (NCT04646603) have been published in Cell Reports Medicine. MR...
Medregen has received IND approval for a phase II, proof of concept to study the Safety and Preliminary Efficacy of MRG-001 in Wou...